INS and obesity due to melanocortin 4 receptor deficiency: We next investigated whether the beneficial effects of carvedilol on gluconeogenic enzymes, hepatic glucose production and muscular insulin signaling pathway were translated to the metabolic benefits of carvedilol treatment in HFD-induced obesity.